Rubrik (NYSE: RBRK) expands AI cybersecurity alliance as Code Guardian enters enterprise delivery push
Read More Pharma Industry News EC approves Novartis’ skin cancer therapy combo Tafinlar and Mekinist for melanoma In a significant development for melanoma treatment, the European Commission (EC) has granted Novartis approval for its combination… bypharmanewsdailySeptember 1, 2018